I thought the deal Pharmaxis did today was interesting...http://www.copyright link/business/...50m-beohringer-ingelheim-deal-20150518-gh45b1
$39m up-front based on interim data that has not yet gone through clinical trials. Doesn't sound too far away from where PYC want to be by year-end, i.e. getting into the clinic with a few internal projects.
Might solve a few cash flow concerns if they could pull something like that through..
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |